SCHEMBL856465

SCHEMBL856465

CCCCOC(=O)C(N)CCCCN

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 1/20 0.51
GNAO1 P09471 1/20 0.51
GNAI1 P63096 1/20 0.51
GSR P00390 1/20 0.50
DPP7 Q9UHL4 4/20 0.48
DPP8 Q6V1X1 2/20 0.48
DPP9 Q86TI2 2/20 0.48
TLR2 O60603 2/20 0.46
NOD1 Q9Y239 1/20 0.46
ALDH1A1 P00352 1/20 0.44
CPB2 Q96IY4 1/20 0.42
DPP4 P27487 1/20 0.42
ATM Q13315 1/20 0.41
RRM1 P23921 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
GRIK1 P39086 1/20 0.39
SLC1A2 P43004 1/20 0.39
SLC1A1 P43005 1/20 0.39
GRIK2 Q13002 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2494020 1.00 GNAI3 (0.51) GNAI3GNAO1GNAI1GSRDPP7
Hydrochloric Acid SCHEMBL9537364 0.98 GNAI3 (0.50) GNAI3GNAO1GNAI1GSRDPP7
SCHEMBL721692 0.98 GNAI3 (0.54) GNAI3GNAO1GNAI1GSRDPP7
SCHEMBL14935740 0.98 GNAI3 (0.54) GNAI3GNAO1GNAI1GSRDPP7
Hydrochloric Acid SCHEMBL10580924 0.98 GNAI3 (0.50) GNAI3GNAO1GNAI1GSRDPP7
SCHEMBL722145 0.98 GNAI3 (0.54) GNAI3GNAO1GNAI1GSRDPP7
Hydrochloric Acid SCHEMBL6428766 0.97 GNAI3 (0.53) GNAI3GNAO1GNAI1GSRDPP7
SCHEMBL6840704 0.95 GNAI3 (0.54) GNAI3GNAO1GNAI1GSRDPP7
SCHEMBL367556 0.95 GNAI3 (0.54) GNAI3GNAO1GNAI1GSRDPP7
SCHEMBL855574 0.95 NOD1 (0.47) GNAI3GNAO1GNAI1GSRDPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720322-A2 ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE BASF SE (DE) 2026-04-08 EP claimed
WO-2024245141-A9 ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE BASF SE (DE) 2025-02-06 WO claimed
WO-2024245141-A2 ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE BASF SE (DE) 2024-12-05 WO claimed
EP-4720322-A2 ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE BASF SE (DE) 2026-04-08 EP disclosed
WO-2024245141-A9 ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE BASF SE (DE) 2025-02-06 WO disclosed
WO-2024245141-A2 ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE BASF SE (DE) 2024-12-05 WO disclosed
EP-3795561-B1 METHOD FOR PRODUCING CARBAMATE AND METHOD FOR PRODUCING ISOCYANATE ASAHI CHEMICAL IND (JP) 2024-11-06 EP disclosed
EP-4446310-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND Asahi Kasei Kabushiki Kaisha (JP) 2024-10-16 EP disclosed
CN-114514012-B External preparation for skin 株式会社高丝 2024-06-14 CN disclosed
WO-2023106377-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND 旭化成株式会社 2023-06-15 WO disclosed
US-11352319-B2 Method for producing carbamate and method for producing isocyanate ASAHI KASEI KABUSHIKI KAISHA (JP) 2022-06-07 US disclosed
EP-1490359-A4 DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE SENSORS FOR MED & SCIENCE INC (US) 2006-08-23 EP disclosed
US-6897209-B2 Labelled factor XIIIa substrates GE HEALTHCARE LIMITED (GB) 2005-05-24 US disclosed
EP-0994730-B1 LABELLED FACTOR XIIIa SUBSTRATES AMERSHAM PLC (GB) 2005-05-04 EP disclosed
EP-1490359-A1 DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE Sensors for Medicine and Science, Inc. (US) 2004-12-29 EP disclosed
US-20040076580-A1 Labelled factor XIIIa substrates AMERSHAM PLC (GB) 2004-04-22 US disclosed
EP-1388014-A2 DETECTION OF GLUCOSE IN SOLUTIONS Sensors for Medicine and Science, Inc. (US) 2004-02-11 EP disclosed
US-6653299-B1 Radiotagged complexes; thrombosis, embolism, atherosclerosis, inflammation, cancer NYCOMED AMERSHAM PLC (GB) 2003-11-25 US disclosed
WO-2003078424-A1 DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE SENSORS FOR MEDICINE AND SCIENCE, INC. (US) 2003-09-25 WO disclosed
WO-2002057788-A2 DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE SENSORS FOR MEDICINE AND SCIENCE, INC. (US) 2002-07-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352319-B2 Method for producing carbamate and method for producing isocyanate CPS1, CA7, CA4 GNAI3 3423/4885GNAO1 1520/4885GNAI1 3549/4885
US-20040076580-A1 Labelled factor XIIIa substrates F13B, F7, F9 GNAI3 4400/4885GNAO1 3934/4885GNAI1 4514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.